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Abstract
Background: Patient-Reported Outcome (PRO) measurement is a method for measuring perceptions of patients on
their health and quality of life. The aim of this paper is to present the results of PRO measurements in total hip and
knee replacement as routinely collected during 20 years of surgery in a university hospital setting.
Methods: Data of consecutive patients between 1993 and 2014 were collected. Health outcomes were measured
pre-surgery and at 3, 6, and 12 months post-surgery. Outcomes for hip replacement were measured with the Harris
Hip Score (HHS) and Oxford Hip Score (OHS). Outcomes for knee replacement were measured with the Western
Ontario and McMaster Universities Arthritis Index (WOMAC) and the Knee Society Score (KSS). A Visual Analog Scale
(VAS) for pain was used. Absolute and relative Minimal Clinically Important Differences (MCID) were estimated.
Generalized estimating equation analysis was used for estimating mean outcomes. Trends over time were analyzed.
Results: The database contained 2,089 patients with hip replacement, and 704 patients with knee replacement. Mean
HHS and OHS scores in primary hip replacement at 12 months post-surgery were 86.7 (SD: 14.5) and 41.1 (SD: 7.5)
respectively. Improvements on the HHS based on absolute MCID was lower for revisions compared to primary hip
replacements, with 72.4% and 87.0% respectively. Mean WOMAC and KSS scores in knee replacement at 12 months
post-surgery were 21.5 (SD: 18.2) and 67.0 (SD: 26.4) respectively. Improvements based on absolute MCID were lowest
for the KSS (62.6%) and highest for VAS pain (85.6%). Trend analysis showed a difference in 1 out of 24 comparisons in
hip replacement and in 2 out of 9 comparisons in knee replacement.
Conclusions: The functional status of a large cohort of patients significantly improved after hip and knee replacement
based on routine data collection. Our study shows the feasibility of the routine collection of PRO data in patients with
total hip and knee replacement. The use of PRO data provides opportunities for continuous quality improvement.
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Background
Hip and knee osteoarthritis are leading causes of disability
resulting in joint pain and stiffness [1, 2]. Joint replace-
ment is a recommended intervention if disability is signifi-
cant and conservative management is ineffective [3].
Prevalence of hip and knee joint replacement in the U.S.
population is estimated at 2.5 and 4.7 million respectively
[4]. Patient-reported outcomes (PRO) are important
variables to quantify the results of surgical intervention
after total hip and knee replacement [5, 6].
PRO measurement is a standardized method for meas-
uring perceptions of patients on their health and health-
related quality of life in relation to health care provided.
Clinicians can use PROs to focus on a patient’s individual
health goals and to guide diagnostic and treatment
decisions. Aggregated across patients, PRO results can be
used to guide efforts to improve clinical quality, for public
reporting, and for value-based payments [7–10]. Large
cohorts have been described in (inter)national registries
for monitoring patients after total hip and knee replace-
ment [11–13]. However, the use of PRO data in registries
is still limited [14, 15]. A body of knowledge needs to be
built to understand outcomes in non-controlled settings.
The department of Orthopedics at Radboudumc has
established a clinical registry in the mid-90s to collect rou-
tine data of clinical and patient-reported health outcomes
of patients after total hip and knee replacement. The aim
of this paper is to present the results of PRO measure-
ments as routinely collected during 20 years of surgery.
The prolonged timeframe with routine data collection
provides an excellent basis for building knowledge, and
the main objective of the paper is to provide normative
PRO data in real world settings.
Methods
Design, setting and participants
Radboudumc is one of the eight University Medical
Centers in the Netherlands. The Orthopedic Department
established a clinical registry in 1993 for the routine
collection of health outcomes prior to and after total hip
and knee replacement. Patients indicated for surgery
were routinely referred to a clinical scoring station for
measurements pre- and post-surgery follow up. The data
was collected and stored in a local database at the
hospital. This observational study presents data of
consecutive patients that received total hip and knee re-
placement between October 1993 and February 2014.
Patient-reported health outcomes
Health outcomes in total hip replacement were measured
with the Harris Hip Score (HHS), the Oxford Hip Score
(OHS), a visual analog scale (VAS) for pain in rest, and a
VAS for pain during exercise. The HHS contains eight
items for pain, function, walking aids, walking, stair
walking, shoe lacing, sitting, and public transportation.
The total score is 0 points if a patient has major problems
on all items and 100 points if a patient has no problems at
all [16]. The OHS contains 12 items related to pain, phys-
ical functioning and (social) activities [16]. We used the
adapted scoring system of Murray where 48 points is the
best score and 0 points is the worst score [17].
Health outcomes in total knee replacement were
measured with the Western Ontario and McMaster Uni-
versities Arthritis Index (WOMAC), the Knee Society
Score (KSS), and a visual analog scale (VAS) for pain. The
WOMAC is a questionnaire containing 24 items in three
domains: pain, joint stiffness, physical functioning. The
total score is 96 points if a patient has major problems on
Table 1 Patient and surgical characteristics of total hip
replacement
Patient characteristics N (%)
Unique patients 2,089
Mean age (SD) 61.4 (15.6)
Age distribution
0-30 years 98 (4.9%)
31-50 years 348 (17.5%)
51-75 years 1187 (59.6%)
≥ 76 years 359 (18.0%)
Sex: male/female 778 (37.2%)/1311 (62.8%)
Surgical characteristics N (%)
Number of surgeries 2,545
Primary hip replacement 1877 (73.8%)
Revision 668 (26.2%)
Complications in primary hip replacement 339 (18.0%)a
Complications in revisions 163 (24.3%)a
aOne or more complications in surgical procedures
Table 2 Patient and surgical characteristics of total knee
replacement
Patient characteristics N (%)
Unique patients 704
Mean age (SD) 65.0 (12.0)
Age distribution
0-30 years 9 (1.3%)
31-50 years 66 (9.7%)
51-75 years 465 (68.7%)
≥ 76 years 137 (20.2%)
Sex: male/female 250 (35.5%)/454
(64.5%)
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all items [18, 19]. The KSS was developed to rate both the
knee prosthesis function and patients’ functional abilities
after total knee replacement. The functional abilities score
is related to walking, walking stairs, and walking aids with
a maximum score of 100 points if patients experience no
problems in their functioning [20]. The KSS was revised
in 2011 expanding the score to five components [21]. In
our study we used the original scoring system for func-
tional ability.
The VAS score is a continuous scale comprised of a line,
100 mm in length, anchored by two descriptors, one for
each symptom extreme. A score of 0 represents “no pain”
and a score of 100 represents “worst imaginable pain” [22].
Measurements
At the Orthopedic Department of Radboudumc, measure-
ments were routinely conducted at the clinical scoring
station under supervision of a medical intern. Data were
collected directly following the indication for surgery and
during routine visits at 3, 6 and 12 months post-surgery.
In addition, data on observed complications during and
following surgery were collected.
Data analysis
We used descriptive analysis to obtain insight in patient
characteristics and complications. We used a well-defined
classification system for determining complications fre-
quently used in the Netherlands [23]. In this complication
system both surgery related orthopedic complication (e.g.
infection, luxation, fracture) are registered as well as other
medical complications (e.g. cardiac, psychiatric). Compli-
cations were registered up to 1 year after surgery.
Measurements were categorized as follows: pre-surgery
(between 6 months pre-surgery and date of surgery); 3-
months (between 1.5 and 4.5 months post-surgery);
6 months (between 4.5 and 9 months post-surgery); and
12 months (between 9 and 15 months post-surgery).
Paired t-tests were used to compare outcomes preopera-
tively and after 12-months follow-up. In addition, we esti-
mated minimal clinically important differences (MCID).
The MCID is defined as the minimal change on a score
that is important to the patient, and is used as parameter
to enable clinical interpretation of change scores. We used
two methods for calculating the proportion of patients
who reached the threshold for a MCID. First, we assigned
a dichotomous score for a clinically important improve-
ment per outcome, based on an absolute MCID cut off
point [24, 25]. Second, we calculated a dichotomous score
per outcome based on 30% improvement from baseline
[26–28] To avoid ceiling effects we only included patients
with potential improvement based on the absolute and
relative cut-off points. Minimally clinically important
Table 3 Uncorrected scores and response rates of the Harris Hip Score and Oxford Hip Score
Harris hip score Oxford hip score
Primary Revision Primary Revision
Score (SD) N % Score (SD) N % Score (SD) N % Score (SD) N %
Pre-surgery 49.7 (16.0) 1252 67 52.6 (19.3) 268 40 22.4 (8.4) 780 41 23.9 (9.9) 196 29
3 months 78.3 (14.5) 794 42 68.6 (15.3) 360 52 36.4 (7.7) 797 42 31.7 (9.4) 382 56
6 months 83.6 (15.3) 699 37 74.0 (17.9) 313 47 39.2 (8.1) 681 36 34.8 (9.7) 314 47
12 months 86.7 (14.5) 789 42 79.7 (17.1) 314 47 41.1 (7.8) 781 42 37.2 (9.1) 315 47
Av. Responsea 47 47 40 45
Primary: primary hip replacement; Response rates for primary hip replacement are based on n = 1877 surgical procedures; Response rates for revisions are based
on n = 688 surgical procedures
aAverage response rates per measurement point. All patients had at least one measurement point at either pre-surgery or at one of the post-surgery follow up
measurements. The distribution of the number of 1, 2, and ≥3measurement points was 30.5%, 27.4%, and 42.1% respectively
Table 4 Uncorrected scores of the VAS pain in total hip replacementa
VAS pain in rest VAS pain during exercise
Primary Revision Primary Revision
Score (SD) N % Score (SD) N % Score (SD) N % Score (SD) N %
Pre-surgery 43.0 (28.2) 806 43 37.0 (29.2) 204 30 68.6 (22.7) 803 43 60.4 (28.1) 202 30
3 months 8.6 (16.6) 842 45 12.6 (20.5) 397 58 16.8 (22.3) 842 45 20.5 (24.9) 397 58
6 months 9.4 (17.3) 716 38 13.8 (20.9) 330 49 17.7 (24.3) 715 38 25.0 (26.9) 330 49
12 months 7.9 (16.8) 805 43 12.1 (21.4) 324 48 14.9 (23.3) 804 43 20.4 (26.7) 324 48
Av Responsea 42 46 42 46
VSS Visual Analog Scale; Primary: primary hip replacement; Response rates for primary hip replacement are based on n = 1877 surgical procedures; Response rates
for revisions are based on n = 688 surgical procedures
a Average response rates per measurement point. All patients had at least one measurement point at either pre-surgery or at one of the post-surgery follow-up
measurements. The distribution of the number of 1, 2, and ≥3measurement points was 30.5%, 27.4%, and 42.1% respectively
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differences between baseline and follow-up scores were
calculated at T = 6 months (scores at 6 months post-
operative compared with pre-operative scores), and at T =
12 months (scores at 12 months post-operative compared
with pre-operative scores).
We estimated MCID after total hip replacement based
on HHS, OHS, and VAS outcomes. HHS scores have
been categorized as follows: >90 excellent; 80–89 good;
79–79 fair, and <70 poor [16, 29]. We categorized
OHS scores of > 41 as excellent, 34–41 good, 27–33
fair, and <27 poor [5, 17, 30, 31]. Based on consensus
we used an improvement of at least one category as
MCID for the HHS and OHS.
We estimated MCID after total knee replacement
based on WOMAC, KSS, and VAS outcomes. The
MCID for the WOMAC has been estimated at around
15–20 points [18], with relative improvements of 21–
41% for its subscales [32–34]. We used a MCID of 20
points based on consensus in the project team. KSS
scores have been categorized as excellent (>80 points),
good (70–79 points), moderate (60–69 points) and
poor (<60 points) [35, 36]. Based on consensus we
used an improvement of at least one category as
MCID for the KSS. For VAS pain a MCID of 20 mm
was used [34].
We used generalized estimating equation (GEE) ana-
lysis for estimating the mean outcomes. A main asset of
GEE analysis is that it uses all observations within one
subject, thus reducing potential bias due to missing data
[37]. GEE analysis is based on repeated measurement
within subjects, allowing for modeling the within-subject
residuals to correct for patient (gender, age) and surgical
(complications) characteristics as confounding variables.
We included baseline scores in the model by using all
observations within one subject in the GEE analysis. We
used registered complications during and post-surgery
and dichotomized them for each patient: 0 complica-
tions versus ≥1 complication.
To analyze trends over time we used 5-year timeframes:
1993–1999; 2000–2004; 2005–2010; 2011–2014 - with
2011–2014 as reference - and included these as independ-
ent variables in the full GEE-models. This resulted in 24
comparisons for primary hip replacement and revisions;
and nine comparisons for total knee replacement.
Results
Patient and surgical characteristics
Patient and surgical characteristics in total hip surgery
are summarized in Table 1. This database contained
Fig. 1 Uncorrected mean scores for HHS and OHS in primary
hip replacement
Fig. 2 Uncorrected Mean scores for HHS and OHS in total hip revision
Fig. 3 Uncorrected mean pain scores in rest and during exercise in
primary hip replacement
Fig. 4 Uncorrected mean pain scores in rest and during exercise in
total hip revision
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2,089 unique patients, with 778 men (37%) and 1311
women (63%). Total number of surgical total hip proce-
dures was 2,545; with 1,877 primary replacements and
668 revisions. In 19.7% of all surgical procedures one or
more complications was registered.
Patient and surgical characteristics in total knee replace-
ment are summarized in Table 2. This database contained
704 unique patients, with 250 men (35.5%) and 454
women (64.5%). The total number of primary total knee
replacements was 799. The database did not contain any
data of total knee revisions. In 13.4% of surgical proce-
dures one or more complications was registered.
Health outcomes after total hip replacement
Uncorrected scores for the HHS and OHS are presented
in Table 3, and uncorrected scores for VAS pain are pre-
sented in Table 4. All patients had at least one measure-
ment point at either pre-surgery or at one of the post-
surgery follow-up measurements. The distribution of the
number of 1, 2, and ≥3 measurement points was 30.5%,
27.4%, and 42.1% respectively. Mean HHS scores for
primary hip replacement pre-surgery and at 12 months
post-surgery were 49.7 (SD: 16.0) and 86.7 (SD: 14.5) re-
spectively. For revisions the pre-surgery and 12-months
post-surgery mean HHS scores were 52.6 (SD: 19.3) and
79.7 (SD: 17.1) respectively. Uncorrected mean scores at
the different measurements for the HHS and OHS after
primary hip replacement and revision are presented in
Fig. 1 and 2 respectively. Uncorrected mean scores at the
different measurements for pain before and after primary
hip replacement and revision are presented in Fig. 3 and 4
respectively. The mean differences between baseline and
12 months follow-up were statistically significant for all
outcomes (p < 0.001).
Table 5 shows the MCID based on absolute cut-off
points. Improvements at 12 months after primary hip re-
placement were lowest for the HHS (87.0%) and highest
for the OHS (93.1%). Improvements on the HHS at
12 months post-surgery based on MCID were substan-
tially lower for revisions compared to primary hip re-
placement, with 72.4% and 87.0% respectively. Table 6
shows the MCID based on minimal 30% improvement
in PROM-scores. The two methods for estimating MCID
showed comparable improvements.
Health outcomes after total knee replacement
Uncorrected scores for the WOMAC, KSS function score
and VAS pain are presented in Table 7. All patients had at
least one measurement point at either pre-surgery or at
one of the post-surgery follow-up measurements. The
Table 5 Absolute MCID after total hip replacement
Primary hip replacementd Revisionse
T = 6 months T = 12 months T = 6 months T = 12 months
Harris Hip Scorea 84.1% (N = 371) 87.0% (N = 416) 62.2% (N = 90) 72.4% (N = 98)
Oxford Hip Scoreb 90.8% (N = 358) 93.1% (N = 378) 69.9% (N = 93) 77.2% (N = 92)
VAS pain (rest)c 89.1% (N = 311) 90.6% (N = 319) 72.7% (N = 77) 79.2% (N = 72)
VAS pain (exercise)c 87.8% (N = 368) 92.6% (N = 392) 70.2% (N = 94) 75.8% (N = 95)
MCID Minimal Clinically Important Differences, HHS Harris Hip Score, OHS Oxford Hip Score, VAS Visual Analog Scale
aHHS scores are categorized as >90 excellent; 80-89 good; 79-79 fair and <70 bad [16, 29]. We defined a clinically relevant improvement as one
category improvement
bOHS scores are categorized as > 41 excellent, 34 -41 good, 27-33 fair, <27 bad [30, 31]. We defined a clinically relevant improvement as one
category improvement
cWe used a difference of 20 mm or more as clinically relevant improvement [34]
dPrimary hip: HHS: 0.7% excluded because of ceiling. OHS: 1.5% excluded because of ceiling. VAS pain rest: 37.2% were excluded because of ceiling. VAS pain
exercise: 4.5% were excluded because of ceiling
eRevision hip: HHS: 4.9% excluded because of ceiling. OHS: 5.6% excluded because of ceiling. VAS pain rest: 28.2% were excluded because of ceiling. 10.9% were
excluded because of ceiling
Table 6 Relative MCID of 30% improvement after total hip replacement
Primary hip replacementb Revisionsc
T = 6 months T = 12 months T = 6 months T = 12 months
Harris Hip Score 84.5% (N = 373) 86.6% (N = 419) 59.3% (N = 91) 66.3% (N = 104)
Oxford Hip Scorea 88.8% (N = 347) 91.5% (N = 365) 61.8% (N = 89) 67.1% (N = 85)
VAS pain (rest)a 88.9% (N = 348) 91.3% (N = 357) 74.4% (N = 73) 76.8% (N = 82)
VAS pain (exercise)a 84.5% (N = 375) 91.1% (N = 403) 67.4% (N = 95) 74.7% (N = 99)
HHS Harris Hip Score, OHS Oxford Hip Score, VAS Visual Analog Scale
aPatients with pre-operative score of 0 points were equaled to 1 point, because it is not possible to establish relative differences from a baseline value 0
bPrimary hip replacement: HHS: 4.9% excluded because of ceiling. OHS: 4.7% excluded because of ceiling. VAS pain rest: 15.4% were excluded because of ceiling.
VAS pain exercise: 2.2% were excluded because of ceiling
cRevisions: HHS: 12.7% excluded because of ceiling. OHS: 9.7% excluded because of ceiling. VAS pain rest: 24% were excluded because of ceiling. VAS pain
exercise: 8.9% were excluded because of ceiling
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distribution of the number of 1, 2 and ≥3 measurement
points was 19%, 30.5%, and 50.5% respectively. Mean
WOMAC scores for primary knee replacement pre-
surgery and at 12 months post-surgery were 52.5 (SD:
16.3) and 21.5 (SD: 18.2) respectively. Mean scores on the
KSS function score were 42.0 (SD: 22.1) pre-surgery and
67.0 (SD: 26.4) 12-months post-surgery. Uncorrected
mean scores at the different measurements for the
WOMAC and VAS pain before and after knee replace-
ment are presented in Fig. 5. The mean differences be-
tween baseline and 12 months follow-up were statistically
significant for all outcomes (p < 0.001).
Table 8 shows the MCID based on absolute cut-off
points. Improvements at 12 months were lowest for
the KSS function score (62.6%) and highest for the
VAS pain (85.6%). Table 9 shows the MCID based on
minimally 30% improvement in PROM-scores. The
two methods for estimating MCID showed compar-
able improvements.
Determinants of health outcomes
In total hip replacement, comparisons in the GEE model
showed better health outcomes for male patients with
higher scores on the OHS and HHS; and less pain in rest
and during exercise. Health outcomes were worse in pa-
tients with complications. The effects are presented in
Table 10. The corrected scores showed a maximum differ-
ence of 2.0 points compared to the uncorrected scores,
and the distribution of scores did not change between the
different measurements.
In total knee replacement, comparisons in the GEE
model showed better scores for male patients on all out-
comes. Age was only statistically significant in estimating
outcomes of the KSS function score. All comparisons
showed a worse score on all outcomes in patients with
complications. The effects are presented in Table 11.
The corrected scores showed a maximum difference of
3.5 points compared to the uncorrected scores, and the
distribution of scores did not change between the differ-
ent measurements.
Trends over time
The trend analysis over time after total hip replacement
showed that VAS pain during exercise after primary hip re-
placement was significantly lower in the period 2000–2004,
compared to the reference period 2011–2014. The trend
analysis over time after total knee replacement showed that
VAS pain was significantly lower in two comparisons for
the periods 1996–1999 and 2000–2004, compared to the
reference period.
Table 7 Uncorrected scores of WOMAC, KSS and VAS pain in total knee replacementb
WOMAC KSS function score VAS pain
Response Response Response
Score (SD) N %a Score (SD) N %a Score (SD) N %a
Preoperative 52.5 (16.3) 385 46 42.0 (22.1) 435 54 64.2 (21.9) 409 51
3 months 24.6 (16.2) 454 57 57.2 (26.3) 486 60 26.0 (23.5) 485 61
6 months 21.9 (16.6) 395 49 64.7 (27.0) 424 53 21.3 (23.8) 422 53
12 months 21.5 (18.2) 450 56 67.0 (26.4) 479 60 19.1 (23.4) 473 59
Av. Responseb 52 57 56
aBased on n = 799 surgical procedures
bAverage response rates per measurement point. All patients had at least one measurement point at either pre-surgery or at one of the post-surgery follow-up
measurements. The distribution of the number of 1, 2 and ≥3 measurement points was 19%, 30.5%, and 50.5% respectively
Fig. 5 Uncorrected mean scores for the WOMAC and VAS pain in
total knee replacement
Table 8 Absolute MCID after total knee replacementd
T = 6 months T = 12 months
WOMACa 75.8% (N = 178) 80.2% (N = 177)
KSS function scoreb 58.7% (N = 213) 62.6% (N = 219)
VAS painc 83.3% (N = 204) 85.6% (N = 201)
aSeveral criteria exist for estimating clinically important improvements in using
the WOMAC. We used a pragmatically chosen cut-off point of at least 20
points improvement
bKSS scores have been categorized in >80 excellent; 70–79 good; 60–69 fair
and <60 bad [36]. We defined a clinically relevant improvement as one
category improvement
cWe used a difference of 20 mm or more as clinically relevant
improvement [34]
dWOMAC: 3.1% were excluded because of ceiling. KSS function score: 4.6%
were excluded because of ceiling. VAS pain: 5.4% were excluded because
of ceiling
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Discussion
Our study showed that the functional status of a large
cohort of patients significantly improved after total hip
and knee replacement, based on routine data collection
in clinical practice. Male patients and patients without
complications improved more than female patients and
patients with complications. The two methods for MCID
showed similar results. Trend analysis over time showed
that patients had more pain after primary hip and knee
replacement in earlier time periods compared to the ref-
erence period 2011–2014.
In total hip replacement the average HHS scores in
our study at 12 months post-surgery are considered
good [16, 29]. In a cohort of almost 600 patients similar
HHS scores were found after primary hip replacement at
12 months post-surgery [38]. The average score on the
OHS in primary total hip replacement at 12 months
post-surgery is considered excellent [17], and compar-
able to outcomes of a cohort of almost 800 patients after
primary hip replacement using the OHS [6].
Improvements in patient-reported outcomes after total
knee replacement have been identified in several studies.
A Canadian study included 298 patients for PRO meas-
urement after total knee replacement [39]. Their data
showed that patients significantly improved on the OKS
and the KSS. A Swiss group of researchers analyzed data
of 98 patients that were followed-up with PRO measure-
ments after total knee replacement [40]. Their data
showed lower pre-operative scores on the WOMAC and
at 12 months follow-up than in our study.
We specified improvements by estimating clinically
relevant improvements based on MCID. Our results
show considerable variations in improvements in total
hip and knee replacement based on mean scores on the
outcome measures, while improvements were consistent
over the two different methods for estimating MCID.
This suggests that presenting MCID might be a good ap-
proach for presenting differences in outcomes within
and between health care organizations.
Beswick et al found that at least 9% of patients with
hip replacement and about 20% of patients with knee re-
placement report unfavorable long term pain outcome
[41]. We did not quantify the share of patients with pain
postoperatively. However, our findings are very much in
line with Beswick’s, as we found that 91% of patients
with primary hip replacement and 81% of patients with
knee replacement reduced their pain scores by at least
30%. A significant share of patients thus experience pain
after surgery, and improvements in the procedure and
improved identification of patients eligible for surgery
may be worthwhile.
Female gender and the incidence of complications
were identified as determinants for lower functional out-
comes. The difference between males and females has
been identified before [38]. The reason for the better
functioning of males after joint replacement is not clear
but is assumed to be related to differences in health
perceptions [42].
The GEE model showed only small differences be-
tween uncorrected and corrected data, without changes
in the distribution between variables for the different
measurements. This implies that missing data were ran-
domly distributed across our cohort. Xie and colleagues
also used a GEE model in estimating change scores and
concluded that the magnitude of change scores on the
selected health outcomes was similar to those with and
without the adjustment of covariates [39].
The GEE modeling including different time frames
showed no improvements in outcomes over time. In
fact, two earlier time frames showed lower pain scores
compared to the 2011–2014 reference period. Therefore
we reject our hypothesis that outcomes after total knee
replacement increased over time. We have no clear
explanation for this. A study by Singh showed that func-
tional limitations and pain worsened over time after
Table 9 Relative MCID of 30% improvement after total knee
replacementb
T = 6 months T = 12 months
WOMAC 82.5% (N = 200) 79% (N = 210)
KSS function scorea 68.1% (N = 213) 68.5% (N = 219)
VAS paina 80.7% (N = 212) 84.9% (N = 205)
aPatients with pre-operative score of 0 points were equaled to 1 point, because it
is not possible to establish relative differences from a baseline value 0
bWOMAC: 0% were removed because of ceiling. KSS function: 4.6% were
removed because of ceiling. VAS pain 2.9% were removed because of ceiling
Table 10 GEE estimates for gender and complications in total hip replacement
Gender (male) Complication (no)
Primary score (95%CI) Revision score (95%CI) Primary score (95%CI) Revision score (95%CI)
HHS 4.6 (3.4,5.8) p < 0001 6.8 (4.4, 9.3) p < 0.001 3.6 (2.0, 5.2) p < 0.001 2.8 (0.005, 5.5) p = 0.05
OHS 3.3 (2.6, 4.) p < 0.001 4.4 (3.0,5.8) p < 0.001 1.8 (0.8, 2.8) p < 0.001 1.9 (0.3, 3.5) p = 0.02
VAS pain in rest -3.6 (-5.3, -1.9) p < 0.001 -5.3 (-8.4, -2.2) p < 0.001 ns ns
VAS pain during exercise -3.7 (-5.7, -1.8) p < 0.001 -8.4 (-12.1,-4.7) P < 0.001 -3.6 (-6.2, -1.0) p = 0.008 ns
GEE Generalized Estimation Equation analysis, HHS Harris Hip Score, OHS Oxford Hip Score, VAS Visual Analog Scale; Primary: primary hip replacement; ns: not
statistically significant
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primary knee replacement, also in contrast with their
hypothesis [43]. A possible explanation may be that early
discharge of patients has become more common over
time, with a negative impact on patient functioning.
During the whole period, we used cemented prosthesis
in hip and knee replacement, without major changes in
the surgical procedure.
The routine collection and presentation of PRO data
after total hip and knee replacement serves several pur-
poses. Clinicians and patients can use individual patient
data to monitor progress over time. At the group level
health outcomes can be used for quality improvement
purposes and for presenting the results to the public.
The department of orthopedics has decided to publish
its data on their website to provide transparency to
patients and stakeholders [44, 45]. The next step is to
use the data for quality improvement purposes, e.g.
via peer assessment of colleagues working in the same
surgical team. The data can also be used for compar-
ing outcomes between hospitals, although require-
ments for validity and reliability are high when
comparing outcomes for accountability and appropri-
ate case-mix adjustment is needed [46, 47].
A considerable amount of work is required making
routine PRO measurement a success [48]. Our data
show the feasibility of routine collection of PRO data
in a hospital setting, and the data will be used for the
Dutch national registry in joint replacement [49]. To
our knowledge, this is the first study presenting PROs
in thousands of orthopedic patients over a prolonged
time frame. Therefore, it represents excellent refer-
ence material for assessing outcomes after surgery
elsewhere.
Our study has several limitations. First, we esti-
mated that the continuous data collection resulted in
the inclusion of about half of all enrolled patients
during our 20-year time frame. Second, the overall re-
sponse rate of included patients was 50%; showing a
large gap in data collection. Third, secular trends over
time may have influenced our results. However, we
found no major impact of trends over time. Our data
showed a high percentage of complications, which
may be explained by the broad definition of a compli-
cation we used; any unexpected medical event was
reported including e.g. urinary infections.
PRO measurement could be an important addition to
(inter)national registries by quantifying optimal out-
comes after total hip and knee replacement procedures
[15]. Our study shows the feasibility of the routine col-
lection of PRO data in total hip and knee replacement.
The data provides opportunities for continuous quality
improvement, and for providing transparency of care in
comparing outcomes between hospitals. An important
aspect in managing the routine collection of data is
ensuring high response rates. Future research should
aim at interpreting outcomes for further improvements
in the care of patients with hip and knee osteoarthritis.
Conclusion
The functional status of a large cohort of patients signifi-
cantly improved after hip and knee replacement based on
routine data collection. This is the first study presenting
PROs in thousands of orthopedic patients over a pro-
longed time frame. Therefore, it represents excellent refer-
ence material for assessing outcomes after surgery
elsewhere. Our study shows the feasibility of the routine
collection of PRO data in patients with total hip and knee
replacement. The use of PRO data provides opportunities
for continuous quality improvement.
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